{"id":586242,"date":"2026-07-16T00:00:00","date_gmt":"2026-07-16T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/hpdaprnm25p-marketaccess-new-mexico-2026-health-plan-analysis\/"},"modified":"2026-08-05T23:02:31","modified_gmt":"2026-08-05T23:02:31","slug":"hpdaprnm25p-marketaccess-new-mexico-2026-health-plan-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/hpdaprnm25p-marketaccess-new-mexico-2026-health-plan-analysis\/","title":{"rendered":"New Mexico | 2026 | Health Plan Analysis"},"content":{"rendered":"<p>National MCO Analyzer provides a clear view of the shifting opportunities and barriers MCOs face in today\u2019s commercial marketplace and offers detailed analysis of the fast-changing Medicare and Medicaid segments. These reports provide event-driven market analysis, integrated with a forecast for each plan in the year ahead, as well as overviews of each MCO\u2019s commercial, Medicare, Medicaid, and pharmacy benefit strategies, including plan designs, formulary, and specialty drug management.<\/p>\n","protected":false},"template":"","class_list":["post-586242","report","type-report","status-publish","hentry","report-gateway-marketaccess","marketaccess-product-health-plan-analysis","marketaccess-state-new-mexico","marketaccess-date-2610"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/586242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=586242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}